Tesla CEO Elon Musk has announced that Neuralink, his brain-chip startup company, has received approval from the US Food and Drug Administration (FDA) for an experimental implant device that will “enable even those who have lost both eyes and their optic nerve to see”.
“The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see. Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time,” the tech billionaire tweeted early Wednesday.
In the tweet on X (formerly Twitter), Musk posted a photo of Geordi La Forge, a character from the sci-fi TV series Star Trek, who is blind from birth but uses different technological devices that allows him to see.
“To set expectations correctly, the vision will first be at low resolution, like Atari graphics, but eventually it has the potential to be better than natural vision and enable you to see in infrared, ultraviolet, or even radar wavelengths, like Geordi La Forge”.
Co-founded by Elon Musk in 2016, Neuralink specialises in developing innovative brain-computer interfaces to transform treatments for neurological disorders.
Neuralink’s technology includes a brain implant that reads neural signals and wirelessly transmits them to external devices, including computers and mobile devices.
Business World reported that Neuralink is also developing an implant that enables paralysed individuals to control digital devices with their thoughts.
Neuralink is also reported to be conducting a clinical trial with three participants to evaluate the device’s effectiveness in aiding individuals with spinal cord injuries.
In August 2024, it was widely reported that Neuralink successfully implanted its brain-computer interface in a second patient, who is now able to control video games and create 3D designs using just their thoughts.
